United States· US:71334-235_544ea7d3-23da-c985-e063-6294a90af6d0
AQVESME
A mitapivat product containing mitapivat, registered in United States by Agios Pharmaceuticals, Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Mitapivat is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AX04 (mitapivat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Mitapivat · ATC B06AX04
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MITAPIVAT
- Manufacturer
- Agios Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- B06AX04
- ATC class
- Mitapivat
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 23, 2026
Packs & prices · 1
- ndc1171334-235-00
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mitapivat in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPYRUKYNDAgios Netherlands B.V., Amsterdam
- FinlandPyrukyndAgios Netherlands B.V.
- BelgiumPyrukynd 100 mgAgios Netherlands
- PolandPyrukyndAgios Netherlands B.V.
- SwedenPyrukynd 100 mg Filmdragerad tablettAgios Netherlands B.V.
- NetherlandsPyrukynd 100 mg, filmomhulde tablettenAgios Netherlands B.V.
- United KingdomPyrukynd 20mg tabletsImported (Netherlands)
- SpainPYRUKYND 20 MG + 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAgios Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pyrukynd
- Liechtenstein · Pyrukynd
- Norway · Pyrukynd
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bea49992-f4dd-4a4b-8498-795cae6bfb27 GET /v1/drugs/bea49992-f4dd-4a4b-8498-795cae6bfb27?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "MITAPIVAT",
"productndc": "71334-235",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA216196",
"marketing_category": "NDA"
}See everything about mitapivat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.